Your browser doesn't support javascript.
loading
De novo CLTC variants are associated with a variable phenotype from mild to severe intellectual disability, microcephaly, hypoplasia of the corpus callosum, and epilepsy.
Nabais Sá, Maria J; Venselaar, Hanka; Wiel, Laurens; Trimouille, Aurélien; Lasseaux, Eulalie; Naudion, Sophie; Lacombe, Didier; Piton, Amélie; Vincent-Delorme, Catherine; Zweier, Christiane; Reis, André; Trollmann, Regina; Ruiz, Anna; Gabau, Elisabeth; Vetro, Annalisa; Guerrini, Renzo; Bakhtiari, Somayeh; Kruer, Michael C; Amor, David J; Cooper, Monica S; Bijlsma, Emilia K; Barakat, Tahsin Stefan; van Dooren, Marieke F; van Slegtenhorst, Marjon; Pfundt, Rolph; Gilissen, Christian; Willemsen, Michèl A; de Vries, Bert B A; de Brouwer, Arjan P M; Koolen, David A.
Afiliação
  • Nabais Sá MJ; Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center (Radboudumc), Nijmegen, The Netherlands.
  • Venselaar H; Center for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences (RIMLS), Radboudumc, Nijmegen, The Netherlands.
  • Wiel L; Center for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences (RIMLS), Radboudumc, Nijmegen, The Netherlands.
  • Trimouille A; Department of Human Genetics, RIMLS, Radboudumc, Nijmegen, The Netherlands.
  • Lasseaux E; Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.
  • Naudion S; Univ. Bordeaux, Maladies Rares: Génétique et Métabolisme (MRGM), Inserm U1211, Bordeaux, France.
  • Lacombe D; Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.
  • Piton A; Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.
  • Vincent-Delorme C; Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.
  • Zweier C; Univ. Bordeaux, Maladies Rares: Génétique et Métabolisme (MRGM), Inserm U1211, Bordeaux, France.
  • Reis A; Institut de Genetique et de Biologie Moleculaire et Cellulaire, Illkirch-Graffenstaden, France.
  • Trollmann R; INSERM U964, Illkirch-Graffenstaden, France.
  • Ruiz A; Service de Génétique Clinique Guy Fontaine Hôpital Jeanne de Flandre, CHRU, Lille, France.
  • Gabau E; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Vetro A; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Guerrini R; Department of Pediatrics, Division of Neuropediatrics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Bakhtiari S; Genetics Laboratory, UDIAT-Centre Diagnòstic, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.
  • Kruer MC; Paediatric Unit, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.
  • Amor DJ; Meyer Children's Hospital, University of Florence, Florence, Italy.
  • Cooper MS; Meyer Children's Hospital, University of Florence, Florence, Italy.
  • Bijlsma EK; Barrow Neurological Institute, Phoenix Children's Hospital & University of Arizona College of Medicine, Phoenix, AZ, USA.
  • Barakat TS; Barrow Neurological Institute, Phoenix Children's Hospital & University of Arizona College of Medicine, Phoenix, AZ, USA.
  • van Dooren MF; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.
  • van Slegtenhorst M; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Australia.
  • Pfundt R; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.
  • Gilissen C; Department of Neurodevelopment & Disability, Royal Children's Hospital, Melbourne, Australia.
  • Willemsen MA; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • de Vries BBA; Department of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • de Brouwer APM; Department of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Koolen DA; Department of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Genet Med ; 22(4): 797-802, 2020 04.
Article em En | MEDLINE | ID: mdl-31776469
ABSTRACT

PURPOSE:

To delineate the genotype-phenotype correlation in individuals with likely pathogenic variants in the CLTC gene.

METHODS:

We describe 13 individuals with de novo CLTC variants. Causality of variants was determined by using the tolerance landscape of CLTC and computer-assisted molecular modeling where applicable. Phenotypic abnormalities observed in the individuals identified with missense and in-frame variants were compared with those with nonsense or frameshift variants in CLTC.

RESULTS:

All de novo variants were judged to be causal. Combining our data with that of 14 previously reported affected individuals (n = 27), all had intellectual disability (ID), ranging from mild to moderate/severe, with or without additional neurologic, behavioral, craniofacial, ophthalmologic, and gastrointestinal features. Microcephaly, hypoplasia of the corpus callosum, and epilepsy were more frequently observed in individuals with missense and in-frame variants than in those with nonsense and frameshift variants. However, this difference was not significant.

CONCLUSIONS:

The wide phenotypic variability associated with likely pathogenic CLTC variants seems to be associated with allelic heterogeneity. The detailed clinical characterization of a larger cohort of individuals with pathogenic CLTC variants is warranted to support the hypothesis that missense and in-frame variants exert a dominant-negative effect, whereas the nonsense and frameshift variants would result in haploinsufficiency.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsia / Deficiência Intelectual / Microcefalia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsia / Deficiência Intelectual / Microcefalia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda